TAKEDA PHARMACEUTICAL CO LTD's Net Worth

$461 Million

Estimate Recalculated Feb 22, 2024 05:22PM EST

Who is TAKEDA PHARMACEUTICAL CO LTD?

TAKEDA PHARMACEUTICAL CO LTD has an estimated net worth of $461 Million. This is based on reported shares across multiple companies, which include Calithera Biosciences, Inc., Xilio Therapeutics, Inc., Theseus Pharmaceuticals, Inc., Day One Biopharmaceuticals, Inc., Translate Bio, Inc., Ovid Therapeutics Inc., BiomX Inc., Phathom Pharmaceuticals, Inc., Mirum Pharmaceuticals, Inc., Cortexyme, Inc., Molecular Templates, Inc., HilleVax, Inc., and Myovant Sciences Ltd..

SEC CIK

TAKEDA PHARMACEUTICAL CO LTD's CIK is 0001395064

Past Insider Trading and Trends

2022 was TAKEDA PHARMACEUTICAL CO LTD's most active year for acquiring shares with 5 total transactions. TAKEDA PHARMACEUTICAL CO LTD's most active month to acquire stocks was the month of June. 2021 was TAKEDA PHARMACEUTICAL CO LTD's most active year for disposing of shares, totalling 58 transactions. TAKEDA PHARMACEUTICAL CO LTD's most active month to dispose stocks was the month of April. 2018 saw TAKEDA PHARMACEUTICAL CO LTD paying a total of $138,543,068.75 for 7,420,625 shares, this is the most they've acquired in one year. In 2020 TAKEDA PHARMACEUTICAL CO LTD cashed out on 7,078,945 shares for a total of $146,169,557.13, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Calithera Biosciences, Inc. (CALA) Snapshot price: $0.03

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Apr 17
Form 4
0
0
Jul 1
Form 3
0
0
No matching records found

Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.64

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.48M
1.48M
Oct 26
Form 3
0
0
No matching records found

Theseus Pharmaceuticals, Inc. (THRX) Snapshot price: $4.1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.62M
1.62M
Oct 12
Form 3
0
0
No matching records found

Day One Biopharmaceuticals, Inc. (DAWN) Snapshot price: $15.83

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-4.63%
-297.27K
$18.49
-$5,496,869.49
6.12M
Dec 7 - Dec 8
Form 4
-1.69%
-110.21K
$18.10
-$1,994,529.59
6.42M
Dec 3 - Dec 6
Form 4
+0.88%
57.22K
6.53M
Nov 24
Form 3
0
0
No matching records found

Translate Bio, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-6.82M
$20.68
-$141,140,834.56
0
Jun 30
Form 4
-0.58%
-40.09K
$19.75
-$791,698.50
6.82M
Jun 3
Form 4
-3.02%
-213.87K
$19.81
-$4,237,024.07
6.87M
Jun 1 - Jun 2
Form 3
0
0
No matching records found